Equinor ASA: Share Buy-Back
| Date | Trading venue | Aggregated daily volume (number of shares) | Weighted average share price (NOK) | Total transaction value (NOK) |
| 14 October | OSE | 450,000 | 274.3837 | 123,472,665.00 |
| CEUX | ||||
| TQEX | ||||
| 15 October | OSE | |||
| CEUX | ||||
| TQEX | ||||
| 16 October | OSE | 356,000 | 267.3008 | 95,159,084.80 |
| CEUX | ||||
| TQEX | ||||
| Total for the period | OSE | 806,000 | 271.2553 | 218,631,749.80 |
| CEUX | ||||
| TQEX | ||||
| Previously disclosed buy-backs under the third tranche of the 2024 programme | OSE | 19,520,236 | 278.5762 | 5,437,873,872.24 |
| CEUX | ||||
| TQEX | ||||
| Total | 19,520,236 | 278.5762 | 5,437,873,872.24 | |
| Total buy-backs under third tranche of the 2024 programme (accumulated) | OSE | 20,326,236 | 278.2859 | 5,656,505,622.04 |
| CEUX | ||||
| TQEX | ||||
| Total | 20,326,236 | 278.2859 | 5,656,505,622.04 |
Following the completion of the above transactions, Equinor ASA owns a total of 47,606,940 own shares, corresponding to 1.70% of Equinor ASA's share capital, including shares under Equinor's share savings programme (excluding shares under Equinor's share savings programme, Equinor owns a total of 39,131,815 own shares, corresponding to 1.40% of the share capital).
This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and that is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
Appendix:
A overview of all transactions made under the buy-back tranche that have been carried out during the above-mentioned time period is attached to this report and available at .
Contact details:
Investor relations
Bård Glad Pedersen, senior vice president Investor Relations,
+47 918 01 791
Media
Sissel Rinde, vice president Media Relations,
+47 412 60 584
Attachment
-
Detailed overview of transactions

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment